Fennec Pharmaceuticals FENC Cash Flow Statement (2009-2026)

NASDAQ FENC
$10.64 +0.06 (+0.57%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Fennec Pharmaceuticals Quarterly Cash Flow Statement

Periods 70 quarters
Latest Jun 2026

Fennec Pharmaceuticals reported cash from operations of $0.05M and free cash flow of $0.05M for the quarter ended Jun 2026, up 101.4% year over year. This cash flow statement covers 70 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-4.19M-4.43M-3.70M-5.07M-8.09M-6.86M-6.05M-5.44M-1.87M-2.68M12.84M-5.55M-5.74M-1.99M-1.17M-3.15M-0.64M-4.79M0.20M1.97M
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles
Amortization of Deferred ChargesAmort. Deferred Charges
0.01M0.01M0.01M0.01M0.06M0.06M0.02M0.09M0.05M0.06M0.72M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Depreciation & Amortization (CF)Dep. & Amort.
Share-based CompensationStock Comp.
0.92M0.92M0.40M1.01M1.85M0.83M1.09M2.54M0.87M0.86M1.19M0.93M1.82M1.12M0.80M1.49M2.22M2.52M0.99M1.71M
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
0.04M0.08M-0.09M-0.01M-0.03M-0.06M-0.03M0.07M0.00M0.01M0.00M0.07M0.00M0.00M
Asset Writedowns and ImpairmentWritedown
1.29M
Other non-cash itemsOther Non-Cash
0.40M0.41M3.91M-0.85M0.08M1.14M-1.16M4.06M-0.05M-0.29M
Change in Working Capital
Change in ReceivablesChange Receivables
0.14M0.76M2.08M4.29M1.46M2.04M4.20M0.18M5.28M0.27M3.44M3.46M-4.51M4.22M
Change in InventoryChange Inventory
0.34M0.52M0.32M0.40M-0.09M0.08M-0.50M-0.07M0.34M0.80M0.28M-0.14M0.29M0.52M
Change in Account PayablesChange Payables
0.48M-0.38M0.45M0.52M0.79M-0.14M0.56M0.06M-0.06M0.84M1.43M-0.76M-0.58M-0.63M2.04M0.66M-0.08M-1.23M1.65M-0.77M
Change in Accrued ExpensesChange Accrued Exp.
0.69M0.02M-0.47M-0.12M0.10M1.83M-0.92M-0.08M-0.27M1.85M0.61M-1.33M0.28M0.12M-0.59M-0.62M1.48M1.93M-2.58M0.64M
Change in Other Operating AssetsOther Assets Change
0.83M-0.20M-0.33M-0.22M-0.21M0.49M-0.13M-0.18M-0.21M0.42M2.05M0.01M-1.68M-0.67M-0.10M2.19M-3.86M6.48M2.07M-2.14M
Change in Other Operating LiabilitiesOther Liabilities Change
25.25M-0.44M0.00M
Other Working Capital ChangesOther WC Changes
-0.83M0.20M0.33M0.22M0.21M-0.49M0.13M0.18M0.21M-0.42M23.20M-0.01M1.24M0.67M0.10M-2.19M3.86M-6.48M-2.07M2.14M
Cash from OperationsCash from Ops.
-2.96M-3.25M-2.86M-3.39M-5.01M-6.80M-5.58M-3.95M-2.76M-4.86M39.05M-8.39M-2.21M-1.47M-4.32M-3.69M1.49M-5.96M2.38M0.05M
Investing Activities
Capital ExpendituresCapex
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
Purchase of InvestmentsInvestments Purchased
Sale and Maturity of InvestmentsInvestments Sold
Change in Acquisitions & DivestmentsChange Acquisitions
Other Investing Activities (as filed)Other investing (as filed)
0.47M0.11M0.22M
Cash from Investing ActivitiesCash from Investing
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
-0.07M
Long-Term Debt RepaymentsLT Debt Repayment
Net Long-Term Debt Issued (Repaid)Net LT Debt
-0.07M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.07M
Change in Capital Stock
Common Stock IssuedStock Issued
0.01M0.02M0.05M0.19M0.68M0.21M0.54M0.22M0.75M0.63M0.35M-0.47M0.80M0.37M-0.19M1.80M42.25M1.32M1.96M
Net Shares Issued and RepurchasedNet Shares Issued
0.01M0.02M0.05M0.19M0.68M0.21M0.54M0.22M0.75M0.63M0.35M-0.47M0.80M0.37M-0.19M1.80M42.25M1.32M1.96M
Net Equity Issued and RepurchasedNet Equity Issued
0.01M0.02M0.05M0.19M0.68M0.21M0.54M0.22M0.75M0.63M0.35M-0.47M0.80M0.37M-0.19M1.80M42.25M1.32M1.96M
Other financing activities (as filed)
0.02M0.21M-0.02M-0.01M-1.76M-0.09M-0.06M-0.01M-0.01M-0.10M-0.05M-1.97M-0.31M-0.94M
Cash from Financing ActivitiesCash from Financing
0.01M0.02M0.05M19.85M0.82M0.19M0.51M0.20M5.73M-1.13M0.26M-0.53M-12.21M0.36M-0.28M1.75M20.80M1.01M1.02M
Additional items
Exchange Rate EffectFX Effect
Change in Cash
-2.96M-3.24M-2.84M-3.34M14.84M-5.98M-5.38M-3.43M-2.56M0.87M37.92M-8.13M-2.73M-13.69M-3.96M-3.97M3.24M14.84M3.39M1.07M
Ending Cash Balance
24.34M21.10M18.26M14.92M29.75M23.77M18.39M14.96M12.40M13.27M51.18M43.05M40.32M26.63M22.68M18.71M21.95M36.79M40.18M41.25M
Free Cash FlowFCF
-2.96M-3.25M-2.86M-3.39M-5.01M-6.80M-5.58M-3.95M-2.76M-4.86M39.05M-8.39M-2.21M-1.47M-4.32M-3.69M1.49M-5.96M2.38M0.05M
Net Cash FlowNCF
-2.96M-3.24M-2.84M-3.34M14.84M-5.98M-5.38M-3.43M-2.56M0.87M37.92M-8.13M-2.73M-13.69M-3.96M-3.97M3.24M14.84M3.39M1.07M

Fennec Pharmaceuticals Cash Flow Statement API

Pull Fennec Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=FENC&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY